Innate Pharma S.A./€IPH
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Innate Pharma S.A.
Ticker
€IPH
Sector
Primary listing
PAR
Industry
Biotechnology
Headquarters
Employees
181
ISIN
FR0010331421
Website
IPH Metrics
BasicAdvanced
€140M
-
-€0.61
0.94
-
Price and volume
Market cap
€140M
Beta
0.94
52-week high
€2.50
52-week low
€1.33
Average daily volume
104K
Financial strength
Current ratio
2.6
Quick ratio
2.499
Long term debt to equity
252.275
Total debt to equity
350.86
Interest coverage (TTM)
-91.12%
Profitability
EBITDA (TTM)
-50.274
Gross margin (TTM)
-158.34%
Net profit margin (TTM)
-245.87%
Operating margin (TTM)
-256.32%
Revenue per employee (TTM)
€110,000
Management effectiveness
Return on assets (TTM)
-22.52%
Return on equity (TTM)
-162.91%
Valuation
Price to revenue (TTM)
6.127
Price to book
14.42
Price to tangible book (TTM)
13.98
Price to free cash flow (TTM)
-16.918
Free cash flow yield (TTM)
-5.91%
Free cash flow per share (TTM)
-8.99%
Growth
Revenue change (TTM)
-67.36%
Earnings per share change (TTM)
548.69%
3-year revenue growth (CAGR)
-6.61%
10-year revenue growth (CAGR)
10.19%
3-year earnings per share growth (CAGR)
-2.76%
10-year earnings per share growth (CAGR)
4.53%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Innate Pharma S.A. stock?
Innate Pharma S.A. (IPH) has a market cap of €140M as of July 03, 2025.
What is the P/E ratio for Innate Pharma S.A. stock?
The price to earnings (P/E) ratio for Innate Pharma S.A. (IPH) stock is 0 as of July 03, 2025.
Does Innate Pharma S.A. stock pay dividends?
No, Innate Pharma S.A. (IPH) stock does not pay dividends to its shareholders as of July 03, 2025.
When is the next Innate Pharma S.A. dividend payment date?
Innate Pharma S.A. (IPH) stock does not pay dividends to its shareholders.
What is the beta indicator for Innate Pharma S.A.?
Innate Pharma S.A. (IPH) has a beta rating of 0.94. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.